MedTrace Logo

Growth of Infants Fed Hydrolysate Formulas

NCT02006992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 195

Last updated 2013-12-12

No results posted yet for this study

Summary

Effects on weight and weight gain will be monitored in healthy term infants fed assigned infant formulas.

Conditions

  • Growth and Tolerance

Interventions

OTHER

RTF Infant Formula

a RTF extensively hydrolyzed infant formula

OTHER

Powder Infant Formula

a powdered extensively hydrolyzed infant formula.

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Marlene Borschel, RD, PhD · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
9 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-03-31
Primary Completion
2000-11-30
Completion
2000-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02006992 on ClinicalTrials.gov